Abstract
Candidemia poses a major threat to ICU patients and is routinely diagnosed by blood culture, which is known for its low sensitivity and long turnaround times. We compared the performance of a novel, Candida-specific multiplex real-time PCR assay (Fungiplex® Candida IVD Real-Time PCR Kit) with blood culture and another established diagnostic real-time PCR assay (LightCycler SeptiFast Test) with respect to Candida detection from whole blood samples. Clinical samples from 58 patients were analyzed by standard blood culture (BC) and simultaneously tested with the Fungiplex Candida PCR (FP) and the SeptiFast test (SF) for molecular detection of Candida spp. Compared to BC, the FP test showed high diagnostic power, with a sensitivity of 100% and a specificity of 94.1%. Overall diagnostic accuracy reached 94.6%. Using SF, we found a sensitivity of 60%, a specificity of 96.1%, and an overall diagnostic accuracy of 92.9%. The Fungiplex Candida PCR has shown good sensitivity and specificity on clinical samples of high-risk patients for direct detection of Candida species in whole blood samples. Together with conventional diagnostics (BC and antigen testing), this new multiplex PCR assay may contribute to a rapid and accurate diagnosis of candidiasis.
Highlights
Yeasts of the genus Candida represent the most prevalent group of fungal pathogens in humans.Predominantly in patients with impaired immune response or upon trauma, Candida species can turn from endogenous colonizers to invasive pathogens
Using SeptiFast test (SF), we found a sensitivity of 60%, a specificity of 96.1%, and an overall diagnostic accuracy of 92.9%
A total of 58 EDTA blood samples from 54 intensive care units (ICUs) patients were assessed for the presence of Candida
Summary
In patients with impaired immune response or upon trauma, Candida species can turn from endogenous colonizers to invasive pathogens. This is of particular significance in hematological or transplant patients. Some other important, yet infrequent, species are, for example, C. guilliermondii, C. orthopsilosis, C. inconspicua, C. nivariensis, and multi-resistant C. auris [3,4]. These species only constitute a small number of all invasive Candida infections [5], but these rare species might become increasingly important in the future, with respect to resistance to antifungals [6]. Candidemia poses a major threat to patients in intensive care units (ICUs)
Sign-in/Register to view highlights & summary Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
